NewslettersHematopoiesis NewsUncategorizedTAS-116 (Pimitespib), an HSP90 Inhibitor, Exhibits Efficacy in Preclinical Models of Adult T Cell LeukemiaBy Justin.choi - November 23, 2021046The authors investigated the anti-adult T cell leukemia/lymphoma effects of a novel oral HSP90 inhibitor TAS-116 and the mechanisms involved in ex vivo and in vivo preclinical models.[Cancer Science] 6445212 BBBBBBBB items 1 apa 0 default asc 1 169259 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/Abstract